USPTO serial 87310311
FILTRIVA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHANG, ELIZABETH YI HSUAN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with FILTRIVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Wakefield, MA
Wakefield, MA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ann Lamport Hammitte
ANN LAMPORT HAMMITTE LANDO & ANASTASI, LLPONE MAIN STREETCAMBRIDGE, MA 02142UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological products containing recombinant proteins for the diagnosis and treatment of infections; biological products containing recombinant proteins for the diagnosis and treatment of bloodstream infections; biological products containing recombinant proteins for the diagnosis and treatment of sepsis; biological products containing recombinant proteins for removal of infectious agents and toxins from blood; diagnostic agents, preparations and substances for bloodstream infections; biological products containing recombinant proteins for diagnosis and treatment of bloodstream infections; biological products containing recombinant proteins or medical diagnosis purposes; diagnostic preparations for medical purposes; medical diagnostic assays for testing of blood and other body fluids; diagnostic preparations for medical purposes for detecting the presence of infectious agents and toxins in blood | ACTIVE | — |
| 010 | Extracorporeal medical device with incorporated proteins for removing infectious agents and toxins from blood | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 1, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 28, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Feb 26, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 26, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 26, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 29, 2017 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 4, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 14, 2017 | NPUB | NOTICE OF PUBLICATION | — |
| May 30, 2017 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| May 29, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 29, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 29, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 1, 2017 | CPRA | PRIORITY ACTION MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Apr 28, 2017 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Apr 18, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 27, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 26, 2017 | NWAP | NEW APPLICATION ENTERED | — |